Issue Date: April 22, 2013
Bristol-Myers Plans Biologics Expansion
Bristol-Myers Squibb will expand its large-scale biologics manufacturing facility in Devens, Mass. The $250 million project will add biologics development and clinical trial production capabilities to the four-year-old site with separate new buildings for each operation. The firm also plans to add 350 employees. “This project represents a significant expansion in both the size and mission of Devens,” says Peter Moesta, head of biologics manufacturing and process development.
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society